Loading...
Delayed Commercialization And Slow Consumables Adoption Will Eventually Support Long-Term Proteomics Potential
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
09 Dec 25
Views
27
09 Dec
US$1.13
AnalystLowTarget's Fair Value
US$2.00
43.5% undervalued intrinsic discount1Y
-36.5%7D
29.0%1Y
-36.5%7D
29.0%You can edit this narrative until Dec 10 10:05 PM. Then, changes will post as Updates.
Author's Valuation
US$243.5% undervalued intrinsic discount
AnalystLowTarget Fair Value